Search Within

Ellen Marlese Basu

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (12)
Groups
  1. Neuroblastoma Service (25)
  2. Pediatrics, Department of (25)
  3. Sloan Kettering Institute Postdocs (25)
  4. GSK Faculty (20)
  5. Epidemiology and Biostatistics (19)
  6. Tow Center for Developmental Oncology (TCDO) (19)

More Groups

People
  1. Shakeel Modak (23)
  2. Brian Kushner (19)
  3. Stephen Roberts (19)
  4. Nai-Kong Cheung (17)
  5. Audrey Mauguen (16)
  6. Neeta Pandit-Taskar (8)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (2)
  5. 2021 (4)
  6. 2020 (3)

More Years

Publications
  1. Pediatric Blood and Cancer (7)
  2. Journal of Clinical Oncology (4)
  3. Cancer Research (2)
  4. Journal of Pediatric Surgery (2)
  5. Cell (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (7)
  2. American Society of Clinical Oncology (4)
  3. American Association for Cancer Research (3)
  4. W.B. Saunders Co-Elsevier Inc. (2)
  5. American Medical Association (1)
  6. Cell Press (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
    Journal Article

    Kushner, B. H.; Modak, S.; Mauguen, A.; Basu, E. M.; Kramer, K.; Roberts, S. S.; Cheung, I. Y.; Cheung, N. K. V.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • N9: Pilot study of novel shortened induction for high-risk neuroblastoma
    Meeting Abstract

    Kushner, B. H.; Mauguen, A.; Basu, E. M.; Cardenas, F. I.; Gerstle, J. T.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Long prime-boost interval and heightened anti-GD2 antibody response to carbohydrate cancer vaccine
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Basu, E. M.; Feng, Y.; Kushner, B. H.; Cheung, N. K.
    Vaccines (2024)

    Fulltext@MSK | Save
  • 18F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Pandit-Taskar, N.; Mauguen, A.; Basu, E.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S.; Schwartz, J.; Modak, S.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • (18)F-MFBG PET imaging in patients with neuroblastoma: Lesion targeting and comparison with MIBG
    Meeting Abstract

    Modak, S.; Mauguen, A.; Basu, E. M.; Price, A.; Behr, G.; Min, R.; Lyashchenko, S. K.; Schwartz, J.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease
    Journal Article

    Fong, C.; Kushner, B. H.; Di Giannatale, A.; Gundem, G.; Li, S.; Roberts, S. S.; Basu, E. M.; Price, A.; Cheung, N. K. V.; Modak, S.
    Frontiers in Oncology (2023)

    Fulltext@MSK | Save
  • Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial
    Meeting Abstract

    Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save